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Aim 
Intramuscular sedation or anaesthesia before intravenous tracer administration is frequently 
required in cats. Since anaesthetics have an effect on neuronal activity and on the circulatory 
system and hence on regional cerebral blood flow (rCBF), one should evaluate their effect on 
99m
Tc-ECD distribution studies. 
In veterinary medicine, medetomidine alone or in combination with ketamine is frequently 
used for intramuscular sedation or anaesthesia. 
The aim of this study was to evaluate the effect of medetomidine and ketamine on rCBF 
measured with 
99m
Tc-ECD. 
 
Materials and methods 
The rCBF was measured in 6 adult cats according to the following protocols. For the first 
protocol the tracer (
99m
Tc-ECD) was injected in the awake cat, 5 to 10 minutes prior to IM 
administration of medetomidine (100 µg/kg) (condition A). For the second and third protocol 
the tracer was injected 15 minutes after IM sedation with medetomidine (100 µg/kg) 
(condition M) or with the combination of medetomidine (100 µg/kg) and ketamine (5 mg/kg) 
(condition MK). Anaesthesia was induced and maintained with propofol. Data were acquired 
with a triple head gamma camera (Triad, Trionix), equipped with multipinhole collimators 
(HiSPECT, Bioscan; 6 holes,  3 mm , resolution 2.4mm). During the acquisition, which started 
15 minutes after induction of anaesthesia, intermittent positive pressure ventilation was 
applied in order to maintain end tidal carbon dioxide (EtCO2) between 35 and 45 mmHg. 
Differences between protocols were evaluated for nineteen regions: bilateral frontal, temporal, 
parietal and occipital cortex, bilateral thalamus, amygdala, basal ganglia and hippocampus 
and for the bulbus olfactorius, cerebellum and cingulate gyrus. These regions were predefined 
on MRI data (7T, Philips) fused with the µSPECT data. Semiquantification of the rCBF was 
performed by normalising the average regional counts to total counts. 
 
Results 
Registered counts were significantly higher in conditions M and MK compared to condition A 
(P<0.05). Tracer uptake in the M-condition was higher, albeit not significantly, in all brain 
regions compared to the MK-condition. 
Significant higher perfusion indices were present in condition A in the subcortical regions 
(thalamus, amygdala, basal ganglia and hippocampus) (P<0.05) compared to the two other 
conditions. 
 
Conclusion 
Medetomidine alone or in combination with ketamine, prior to injection of 
99m
Tc-ECD, 
provokes not only a generally increased tracer uptake in all brain regions, but also regional 
blood flow alterations. Thus caution is needed when evaluating rCBF under medetomidine or 
medetomidine/ketamine sedation/anaesthesia. Further studies are needed to evaluate the effect 
of these rCBF alterations on neurotransmitter studies. 
 
